Abstract
Peptides are widely used for the diagnostics, prevention, and therapy of certain human diseases. How useful can they be for the disease caused by the SARS-CoV-2 coronavirus? In this review, we discuss the possibility of using synthetic and recombinant peptides and polypeptides for prevention of COVID-19 via blocking the interaction between the virus and its main receptor ACE2, as well as components of antiviral vaccines, in particular, against new emerging virus variants.
Keywords: ACE2; SARS-CoV-2; T-cell epitopes; vaccine.
All Keywords
【저자키워드】 SARS-CoV-2, ACE2, Vaccine, T-cell epitopes, 【초록키워드】 Vaccine, therapy, Antiviral, Vaccines, peptide, virus, diagnostics, virus variants, T-cell, Interaction, human diseases, component, polypeptide, main receptor, prevention of COVID-19, caused, the disease, the SARS-CoV-2, 【제목키워드】 STOP,
【저자키워드】 SARS-CoV-2, ACE2, Vaccine, T-cell epitopes, 【초록키워드】 Vaccine, therapy, Antiviral, Vaccines, peptide, virus, diagnostics, virus variants, T-cell, Interaction, human diseases, component, polypeptide, main receptor, prevention of COVID-19, caused, the disease, the SARS-CoV-2, 【제목키워드】 STOP,